GlassScriptPhysician profile
Amanda L Jackson
NPI 1245498864
$91,848.59
in general payments reported to CMS, 2019-2025
23 companies · $1,621 in 2025
The $1,621 reported for 2025 was more than what 76% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,845 · 2020: $28K · 2021: $3,157 · 2022: $28K · 2023: $7,584 · 2024: $14K · 2025: $1,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $3,067 · Food and Beverage: $1,973 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,981.81 |
| Travel and Lodging | $3,067.45 |
| Food and Beverage | $1,973.43 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $66,246.97 | 2019-2024 | |
| Eisai INC. | $8,299.02 | 2020-2022 | |
| Ethicon Endo-Surgery INC. | $5,734.61 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $3,995.58 | 2022-2025 | Lynparza |
| Seagen INC. | $2,985.00 | 2020-2021 | |
| Intuitive Surgical, INC. | $2,207.08 | 2022-2024 | |
| Medical Device Business Services, INC. | $1,580.83 | 2024-2025 | Harmonic |
| Genmab U.S., INC. | $317.17 | 2021-2025 | Tivdak |
| Glaxosmithkline, LLC. | $186.23 | 2021-2023 | Jemperli, Zejula |
| Merck Sharp & Dohme LLC | $109.90 | 2020-2022 | |
| Abbvie INC. | $72.80 | 2019 | |
| Clovis Oncology, INC. | $26.32 | 2019-2020 | |
| Servier Pharmaceuticals LLC | $19.02 | 2023 | |
| Immunogen, INC. | $18.51 | 2023 | Elahere |
| Tactile Systems Technology INC | $14.78 | 2023 | Entre Plus, Flexitouch Plus |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $13.95 | 2019 | |
| Janssen Biotech, INC. | $11.50 | 2020 | |
| Ethicon US, LLC | $9.32 | 2024 | Vistaseal |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.